| Code: MTA13301 | Publication Date: Jul 2026 |
The following is a data-backed list of the leading South Korea Tardive Dyskinesia companies, compiled through 6Wresearch's proprietary research and validated by in-house industry analysts. These companies represent the key players shaping competition in the South Korea Tardive Dyskinesia Industry, including Handok, Teva Pharmaceutical Industries, and other established names.
For detailed forecasts, data tables, and competitive benchmarking,
Explore the full South Korea Tardive Dyskinesia Industry.
| Company Name | Handok Inc. |
|---|---|
| Established Year | 1954 |
| Headquarters | Seoul, South Korea |
| Official Website | Click Here |
Collaborates closely with global innovators to distribute advanced neurological treatments and therapeutics for movement disorders like tardive dyskinesia.
| Company Name | Teva-Handok |
|---|---|
| Established Year | 2019 (Joint Venture) |
| Headquarters | Seoul, South Korea |
| Official Website | Click Here |
Brings specialized VMAT2 inhibitor treatments such as Austedo to the South Korean healthcare sector, addressing drug-induced involuntary movements.
| Company Name | Mitsubishi Tanabe Pharma Corporation |
|---|---|
| Established Year | 1678 (Group) |
| Headquarters | Osaka, Japan (Regional Hub: Seoul) |
| Official Website | Click Here |
Developed and secured regional regulatory approvals for specialized therapeutic capsules targeting vesicular monoamine transporter type 2 for neurological conditions.
| Company Name | Neurocrine Biosciences |
|---|---|
| Established Year | 1992 |
| Headquarters | California, USA (Regional Partnerships) |
| Official Website | Click Here |
A pioneering neuroscience biopharmaceutical enterprise discovering life-changing treatments for under-addressed neurological and neuropsychiatric disorders.
| Company Name | Celltrion Pharm |
|---|---|
| Established Year | 2000 |
| Headquarters | Cheongju, South Korea (Seoul Office) |
| Official Website | Click Here |
A prominent domestic pharmaceutical leader expanding its portfolio into advanced central nervous system therapeutics and specialized clinical formulations.
| Company Name | Hanmi Pharm |
|---|---|
| Established Year | 1973 |
| Headquarters | Seoul, South Korea |
| Official Website | Click Here |
Drives extensive local research, development, and distribution of diverse prescription medications, supporting complex psychiatric and neurological care pathways.
| Company Name | Yuhan Corporation |
|---|---|
| Established Year | 1926 |
| Headquarters | Seoul, South Korea |
| Official Website | Click Here |
One of South Korea's most trusted pharmaceutical institutions, providing robust nationwide logistics and supply chains for essential specialty medicines.
| Company Name | SK Biopharmaceuticals |
|---|---|
| Established Year | 2011 |
| Headquarters | Seongnam, South Korea (Seoul Metro) |
| Official Website | Click Here |
Focuses on the discovery and commercialization of innovative neuro-centric drugs, strengthening South Korea's footprint in advanced brain disorder treatments.
| Company Name | Lundbeck Korea |
|---|---|
| Established Year | 2002 (Local Subsidiary) |
| Headquarters | Copenhagen, Denmark (Regional Hub: Seoul) |
| Official Website | Click Here |
Dedicated exclusively to brain diseases, supplying specialized psychiatric medications and supporting clinical education for movement complications.
| Company Name | Pfizer Korea |
|---|---|
| Established Year | 1959 (in Korea) |
| Headquarters | New York, USA (Regional Hub: Seoul) |
| Official Website | Click Here |
Supplies established pharmaceutical portfolios and supports healthcare professionals managing complex multi-drug therapeutic regimens in patient groups.